Drostanolone propionate
- CAS NO.:521-12-0
- Empirical Formula: C23H36O3
- Molecular Weight: 360.54
- MDL number: MFCD01669961
- EINECS: 208-303-1
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-09-23 15:54:53
What is Drostanolone propionate?
Absorption
Well absorbed following parenteral administration.
Toxicity
Side effects include virilization (masculine traits in women), acne, fluid retention, and hypercalcemia.
Description
17b-Hydroxy-2a-methyl-5a-androstan-3-one propionate, also known as drostanolone propionate, is a synthetic anabolic-androgenic steroid. It has similar properties to dihydrotestosterone. It had been used for the treatment of breast cancer in the past. However, it is now mainly used by athletes and bodybuilder as an anabolic steroid. It has two major effects including enhancing the physical/athletic performance (such as endurance and strength) and enhancing physical health (muscle buildup and fat loss). It should be administrated via intramuscular injection instead of oral taking.
Chemical properties
White Solid
Originator
Drolban,Lilly,US,1961
The Uses of Drostanolone propionate
Drostanolone propionate is the propionate salt form of dromostanolone, a synthetic anabolic steroid related to dihydrotestosterone that has antiestrogenic effects. It is used as an antineoplastic for use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal. Now it is used to help improve athletic performance and muscle gain.
Indications
For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
Definition
ChEBI: Drostanolone propionate is a steroid ester and a 3-oxo-5alpha-steroid. It has a role as an antineoplastic agent. It is functionally related to a metholone.
Preparation
Drostanolone propionate is prepared from 9,11-dehydro-17a-methyl-testosterone raw material, reacts with lithium chloride and N-chlorosuccinimide to generate 9a,11-dichloro-17a-methyl- 95 testosterone is further prepared by esterification with propionin.
Manufacturing Process
A suspension of 10 grams of dihydrotestosterone in 500 cc of anhydrous
benzene free of thiophene was mixed with10 cc of ethyl formate and 3 grams
of sodium hydride and the mixture was stirred for 5 hours under an
atmosphere of nitrogen and at a temperature of approximately 25°C. The
resulting suspension was filtered, the resulting mixture of the sodium salt of
the hydroxymethylene compound and the excess of sodium hydride was
washed with benzene and dried. This mixture was slowly added to a
vigorously stirred solution of 20 cc of concentrated hydrochloric acid in 500 cc
of water, and the stirring was continued for 30 minutes at the end of which
the precipitate was collected and well washed with distilled water. After drying
in vacuo, there was obtained 9.7 grams of 2-hydroxymethylenedihydrotestosterone.
A mixture of 1 gram of 2-hydroxymethylene-dihydrotestosterone, 10 cc of
pyridine and 2 cc of propionic anhydride was allowed to react at room
temperature for 16 hours and then poured into water. The resulting
suspension was heated for 1 hour on the steam bath to hydrolyze the excess
of propionic anhydride, cooled and extracted with methylene dichloride. The
extract was consecutively washed with dilute hydrochloric acid, sodium
bicarbonate solution and water, dried over anhydrous sodium sulfate and
evaporated to dryness under vacuum. There was thus obtained the
dipropionate of 2-hydroxymethylenedihydrotestosterone which was treated
with hydrogen, in methanol solution.
When the uptake of hydrogen ceased, the catalyst was filtered and the
solution was evaporated to dryness under vacuum. The residue was dissolved
in a mixture of benzene-hexane, transferred to a chromatographic column
with neutral alumina and the product was eluted with mixtures of benzenehexane, gradually increasing the proportion of benzene in the mixture.
Crystallization of the eluates from acetone-hexane yielded the propionate of
2α-methyldihydrotestosterone.
brand name
Drolban (Lilly).
Therapeutic Function
Cancer chemotherapy
Pharmacokinetics
Dromostanolone is a synthetic androgen, or male hormone, similar to testosterone. Dromostanolone works by attaching itself to androgen receptors; this causes it to interact with the parts of the cell involved in the making of proteins. It may cause an increase in the synthesis of some proteins or a decrease in the synthesis of others. These proteins have a variety of effects, including blocking the growth of some types of breast cancer cells, stimulating cells that cause male sexual characteristics, and stimulating the production of red blood cells.
Side Effects
As to be expected with all steroids, it's essential that you're aware of all potential side effects of Drostanolone propionate, before you consider a cycle. Side effects of drostanolone propionate include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It has no risk of liver damage.
Metabolism
Not Available
References
https://en.wikipedia.org/wiki/Drostanolone_propionate
http://www.chemspider.com/Chemical-Structure.194604.html
http://steroid.es/drostanolone.html
Chowdhury, M. S., et al. "A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma. " 2.3(1976):203-206.
Properties of Drostanolone propionate
Melting point: | 114-120°C |
Boiling point: | 432.53°C (rough estimate) |
alpha | D +24° |
Density | 1.0669 (rough estimate) |
refractive index | 1.4700 (estimate) |
storage temp. | Controlled Substance, -20°C Freezer |
solubility | DMF:30.0(Max Conc. mg/mL);83.21(Max Conc. mM) DMSO:24.0(Max Conc. mg/mL);66.57(Max Conc. mM) Ethanol:2.0(Max Conc. mg/mL);5.55(Max Conc. mM) |
form | A crystalline solid |
InChI | InChI=1/C23H36O3/c1-5-21(25)26-20-9-8-17-16-7-6-15-12-19(24)14(2)13-23(15,4)18(16)10-11-22(17,20)3/h14-18,20H,5-13H2,1-4H3/t14-,15+,16+,17+,18+,20+,22+,23+/s3 |
CAS DataBase Reference | 521-12-0(CAS DataBase Reference) |
NIST Chemistry Reference | Dromostanolone propionate(521-12-0) |
Safety information for Drostanolone propionate
Signal word | Danger |
Pictogram(s) |
Health Hazard GHS08 |
GHS Hazard Statements |
H351:Carcinogenicity |
Precautionary Statement Codes |
P201:Obtain special instructions before use. P202:Do not handle until all safety precautions have been read and understood. P280:Wear protective gloves/protective clothing/eye protection/face protection. P308+P313:IF exposed or concerned: Get medical advice/attention. P405:Store locked up. P501:Dispose of contents/container to..… |
Computed Descriptors for Drostanolone propionate
InChIKey | NOTIQUSPUUHHEH-DEMPVMEFNA-N |
SMILES | C[C@]12C[C@@H](C)C(=O)C[C@]1([H])CC[C@@]1([H])[C@]3([H])CC[C@H](OC(=O)CC)[C@@]3(C)CC[C@]21[H] |&1:1,3,8,12,14,18,24,28,r| |
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
88491-46-7 98%View Details
88491-46-7 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4